MedTrace Logo

Drug Order for Rapid Sequence Intubation

NCT03420950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 335

Last updated 2022-02-03

No results posted yet for this study

Summary

This is a randomized, blinded trial comparing the order of drug administration for rapid sequence intubation in the Emergency Department.

Conditions

  • Acute Respiratory Failure

Interventions

OTHER

Rapid sequence intubation: sedative first

Sedative first

OTHER

Rapid sequence intubation: paralytic first

Paralytic first

Sponsors & Collaborators

  • Hennepin Healthcare Research Institute

    lead OTHER

Principal Investigators

  • Brian Driver, MD · Hennepin County Medical Center, Minneapolis

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2021-09-29
Completion
2021-09-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03420950 on ClinicalTrials.gov